BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 27063176)

  • 1. Phospholipase Cδ1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/β- catenin/MMP7 signalling.
    Shao Q; Luo X; Yang D; Wang C; Cheng Q; Xiang T; Ren G
    Oncotarget; 2017 Apr; 8(17):29056-29066. PubMed ID: 28423710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner.
    Dey N; Young B; Abramovitz M; Bouzyk M; Barwick B; De P; Leyland-Jones B
    PLoS One; 2013; 8(10):e77425. PubMed ID: 24143235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of BMI1 Gene on Regulating Apoptosis, Invasion, and Migration of HEC-1B Cells Induced by Ionizing Radiation.
    Chen L; Luo W; Ji P; Li Z; Yan Y; Zhou Q
    J Healthc Eng; 2022; 2022():7052066. PubMed ID: 35281533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CTNNB1 mutations and matrix metalloproteinases (MMPs) in anti-angiogenesis treatment of endometrial carcinoma.
    Berger AA; Kawaler EA; Dao F; Misirlioglu S; Fernandez EA; Olvera N; Van Oudenhove E; DeLair D; Levine DA
    Gynecol Oncol; 2022 Nov; 167(2):323-333. PubMed ID: 36150916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAGP1 maintains tumorigenicity and angiogenesis of laryngeal cancer by activating Wnt/β-catenin/MMP7 pathway.
    Lv F; Li X; Wang Y; Hao L
    Carcinogenesis; 2024 Apr; 45(4):220-234. PubMed ID: 36645203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase/Fas ligand (MMP/FasL) interaction dynamics in COVID-19: An
    Saleki K; Aram C; Alijanizadeh P; Khanmirzaei MH; Vaziri Z; Ramzankhah M; Azadmehr A
    Heliyon; 2024 May; 10(10):e30898. PubMed ID: 38803919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N
    Chen RX; Chen X; Xia LP; Zhang JX; Pan ZZ; Ma XD; Han K; Chen JW; Judde JG; Deas O; Wang F; Ma NF; Guan X; Yun JP; Wang FW; Xu RH; Dan Xie
    Nat Commun; 2019 Oct; 10(1):4695. PubMed ID: 31619685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NRF1-regulated CircNSUN2 promotes lymphoma progression through activating Wnt signaling pathway via stabilizing HMGA1.
    Wang L; Yang B; Xu Z; Song X; Gong Z; Xue S; Kong L
    Cell Cycle; 2021 May; 20(9):819-828. PubMed ID: 33858292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM11 promotes lymphomas by activating the β-catenin signaling and Axin1 ubiquitination degradation.
    Hou Y; Ding M; Wang C; Yang X; Ye T; Yu H
    Exp Cell Res; 2020 Feb; 387(2):111750. PubMed ID: 31786079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Overexpression of Axin inhibits lymphoma cell invasion and metastasis in vitro by down-regulating β-catenin and MMP7/MMP9].
    Li ZJ; Ye JZ; Zhan LY; Zheng ML
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):423-8. PubMed ID: 27063176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCDH10 inhibits invasion of lymphoma cells by regulating β-catenin.
    Zhang QK; Li HY; Wei XF; Feng YF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4835-4841. PubMed ID: 31210316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [mRNA and Protein Expression of AXIN,β-Catenin, MMP7 and MMP9 and Their Relationship in Lymphoma Cells].
    Zhang HY; Wu L; Ma DL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1105-1110. PubMed ID: 30111415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zbed3 promotes proliferation and invasion of lung cancer partly through regulating the function of Axin-Gsk3β complex.
    Shi X; Zhao Y; Fan C
    J Cell Mol Med; 2019 Feb; 23(2):1014-1021. PubMed ID: 30417576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells.
    Yang LH; Xu HT; Han Y; Li QC; Liu Y; Zhao Y; Yang ZQ; Dong QZ; Miao Y; Dai SD; Wang EH
    Mol Cancer; 2010 Feb; 9():25. PubMed ID: 20122174
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.